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Anticancer activityCell penetrating peptides (CPPs) are usually short, highly cationic peptides that are capable of crossing the cell
membrane and transport cargos of varied size and nature in cells by energy- and receptor-independent mecha-
nisms. An additional potential is the newly discovered anti-tumor activity of certain CPPs, including RW16
(RRWRRWWRRWWRRWRR)which is derived from penetratin and is investigated here. The use of CPPs in ther-
apeutics, diagnosis and potential application as anti-tumor agents increases the necessity of understanding their
mode of action, a subject yet not totally understood. With this in mind, themembrane interaction and perturba-
tion mechanisms of RW16 with both zwitterionic and anionic lipid model systems (used as representative
models of healthy vs tumor cells) were investigated using a large panoply of biophysical techniques. It was
shown that RW16 autoassociates and that its oligomerization state highly inﬂuences its membrane interaction.
Overall a stronger association and perturbation of anionic membranes was observed, especially in the presence
of oligomeric peptide, when compared to zwitterionic ones. This might explain, at least in part, the anti-tumor
activity and so the selective interaction with cancer cells whose membranes have been shown to be especially
anionic. Hydrophobic contacts between the peptide and lipids were also shown to play an important role in
the interaction. That probably results from the tryptophan insertion into the fatty acid lipid area following a
peptide ﬂip after the ﬁrst electrostatic recognition. A model is presented that reﬂects the ensemble of results.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cell-penetrating peptides are short peptides that have the ability
to translocate into cells in an energy- and receptor-independentmanner.
CPPs are proven to be vehicles for the intracellular delivery ofmacromol-
ecules such as oligonucleotides, peptides and proteins, nano-particles
and liposomes [1]. Therefore these molecules present a great potential
in therapeutics and diagnosis. Indeed, the number of applications using
CPPs is quickly increasing, with so far more than 300 studies from in
vitro to in vivo using CPP-based strategies [2–6]. Since their discoveryino pentanoic acid; CD, Circu-
penetrating peptide; DLS, Dy-
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rights reserved.in the 1990s an important number of research groups have focused in
the understanding of their mode of action with the ﬁnal attempt of
improving their internalization and speciﬁcity. It is now mostly agreed
that their uptake occurs through both endocytotic and non-endocytotic
pathways but themolecular requirements for an efﬁcient internalization
are not fully understood [7]. It appears that their uptake ability depends
on their amino acid sequence and spacing [8]. Despite their uptake
being endocytotic or not, the ﬁrst barrier that these peptides encoun-
ter is the plasma membrane which prevents direct translocation of
macromolecules.
Herein, we have focused in the understanding of the membrane
interaction and perturbation by a CPP derived from penetratin SAR
(structure–activity relationship) studies. The peptide is RW16
(RRWRRWWRRWWRRWRR), a 16 residue amphipathic peptide shown
to be a good CPP [9]. Moreover this peptide was reported to possess
anti-tumor activity, namely, to decrease the mobility and proliferation
of cancer cells (EF cells), this without being cytotoxic (up to 20 μM; in
both NIH 3T3 and EF cells) [10]. The mechanism of action of this peptide
is not well understood. Lamaziere et al. have shown that RW16 induced
GUVs (Giant Unilamellar Vesicles) adhesion and vesicle aggregation for
certain lipid compositions. Aside from these liposome modiﬁcations
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to the cells [11]. It is interesting to notice that recent studies have shown
that some CPPs preferentially accumulate in cancer cells [12–14]. This
selectivity toward cancer vs healthy cells might be directly correlated
with the richness in anionic components in their cellmembranes. Indeed
several studies indicated that cancer cellmembranes overexpress certain
proteoglycans such as glypicans and syndecans which are implicated in
several aspects of tumorigenesis such as cell adhesion, growth and
motility [15–18]. Additionally, when cells become apoptotic their trans-
membrane asymmetry is strongly perturbed with an increase in the
levels of phosphatidylserine (PS) in the outer membrane leaﬂet, of up
to 9% [19]. These components in the cancer cell membranes render
them additionally anionic relative to healthy cell membranes which
can be favorable for the interactionwith cationicmolecules such as CPPs.
In the present study the structural characterization and interaction
mechanism of RW16 with different membrane models (composed of
zwitterionic and/or anionic lipids) was performed. The zwitterionic
lipid system was employed as a mimic of the outer leaﬂet of a healthy
eukaryotic cell and the anionic system to model the enhanced anionic
character of apoptotic cells. The interaction, afﬁnity, perturbation of
the lipidmodel systems uponRW16 interaction aswell as the structural
changes occurring in the peptide upon this interactionwas investigated.
Studies were performed using several biophysical techniques and
lipid model systems to mimic healthy and cancer cell membranes.
CPPs and antimicrobial peptides share common features namely
their cationic nature [20] and in the particular case of RW16 the
amphipathicity. Additionally several cell penetrating peptides have
been reported to possess antimicrobial activity, including penetratin
and its analogues [21–25]. Therefore the antimicrobial activities of
RW16 were investigated against Escherichia coli, Staphylococcus aureus
and Klebsiella pneumoniae. Furthermore efﬁcient antimicrobial peptides
have also been shown to possess anticancer activity [26–28].
The analysis of the results obtained was complicated by the fact
that RW16 alone autoassociates at increasing peptide concentrations,
a property arising from its amphipathic character. Overall the studies
indicate an enhanced interaction and perturbation of RW16with anionic
vs zwitterionic lipidswhich is speciallymarkedwhen the peptide is in its
oligomerized form. While this would indicate that electrostatic interac-
tions are important in the P/L interaction, which is rather expected, the
studies show that important hydrophobic interactions take place. Such
interactions can be explained by a peptideﬂip, following the initial elec-
trostatic contacts, probably around the Arg with the insertion of Trp
residues in the fatty acid chain core. A model is proposed to explain
the markedly distinct behavior of RW16 in interaction with anionic vs
zwitterionic lipids that also takes into account the peptide oligomeriza-
tion state. This preferential interaction and perturbation in membranes
enriched in anionic components may explain the reported anti-tumor
activity of this peptide and CPPs in general.
2. Materials & methods
2.1. Materials
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL).
The calcein was obtained from Sigma. Biot(O2)-Apa-RW16-NH2
(RRWRRWWRRWWRRWRR) synthesis and puriﬁcation was performed
using Boc solid phase strategy. The bacterial strainswere kindly provided
by the laboratory of Pierre Nicolas.
2.2. Antimicrobial activity
Gram-positive eubacteria (S. aureus) and Gram-negative eubacteria
(E. coli 363 and K. pneumoniae) were cultured as described previously
[29]. The minimal inhibitory concentrations (MICs) of peptides were
determined in 96-well microtitration plates by growing the bacteria in
the presence of 2-fold serial dilutions of peptide. Aliquots (10 μL) ofeach serial dilutionwere incubated for 16 h at 37 °Cwith 100 μL of a sus-
pension of a midlogarithmic phase culture of bacteria, at a starting absor-
bance A630=0.01 in Poor-Broth nutrient medium (1% bactotryptone and
0.5%NaCl,w/v) (peptideﬁnal concentrations ranged from0.1 to 100 μM).
Inhibition of growth was assayed by measuring the absorbance at
630 nm. The MIC was deﬁned as the lowest concentration of peptide
that inhibited the growth of about 99% of the cells. Bacteria that was
incubated with the peptide corresponding to the MIC was plated out
on solid culturemedium containing 1% noble agar to distinguish between
lytic and non-lytic effects. The peptide was considered to be lytic if after
overnight incubation with the peptide (at the MIC concentration) the
bacteria development was inhibited and non-lytic when the bacteria
was able to re-grow upon peptide incubation. All assays were performed
in triplicate plus positive controls without the peptide and negative
controls with 0.7% formaldehyde.
2.3. Preparation of liposomes
All liposomes were prepared by initially dissolving the appropriate
amount of phospholipids, to obtain the desired concentration, in chloro-
form andmethanol (2/1 v/v) to ensure the completemixing of the com-
ponents. A lipid ﬁlm was then formed by removing the solvent using a
streamof N2 (g) followed by 3 h vacuum. To formMLVs, the dried lipids
were dispersed in buffer (either Tris 10 mM, 150 mMNaCl, 2 mMEDTA
pH 7.4 or phosphate 10 mM, NaCl 150 mM, EDTA 2 mM pH 7.4 buffer
depending on the technique used) and thorough vortexed. To form
LUVs, the MLV dispersion was run through ﬁve freeze/thawing cycles
and passed through a mini-extruder equipped with two stacked
0.1 μm polycarbonate ﬁlters (Avanti, Alabaster, AL).
2.4. Turbidity
Turbidity of LUVs was followed by measuring the absorbance at
436 nm upon addition of increasing peptide concentration (P/L ratios
of 1/100, 1/50, 1/25, 1/10were used). Themeasurementswere acquired
on a Jasco V-630 spectrometer at room temperature (~22 °C).
2.5. Dynamic Light Scattering (DLS)
DLS measurements were performed using an ALV laser goniome-
ter, equipped with a 22 mW HeNe linearly polarized laser operating
at 632.8 nm and an ALV-5000/EPP multiple τ digital correlator with
125 ns initial sampling time. Measurements were performed at a
scattering angle of 90° and the intensity correlation functions were
analyzed using the software provided by the company, to give the hy-
drodynamic radius (Rh) of the scattering particles. All measurements
were performed at room temperature in phosphate buffer. To get an
insight into the inﬂuence of RW16 on LUVs integrity, 100 μL of a
1 mg/mL LUV solution was analyzed by DLS, followed by addition
of a small volume of RW16 (1 mM) to the LUV suspension to the de-
sired P/L ratio (1/100, 1/50, 1/25, 1/10) and particle size again analyzed,
immediately. The same measurements were performed in the absence
of LUVs to determine whether the peptide auto-aggregates.
2.6. Tryptophan ﬂuorescence
Small volumes of LUV suspensions (1 mM) were successively
added to the peptide solution (0.5 μM) to obtain different P/L ratios:
1/10, 1/25, 1/50 and 1/100. After 2 min incubation, ﬂuorescence spec-
tra were recorded using an excitation wavelength (λexc) of 278 nm
(5 nm bandwidth) and emission wavelength (λem) in the interval
from 300 nm to 500 nm (10 nm bandwidth). The scan speed was
200 nm/min and the spectra were averaged over 10 accumulations.
Fluorescence measurements were made on a Perkin Elmer LS55 spec-
trometer (Buckinghamshire, UK). The blue shift was plotted against
the lipid concentration and ﬁtted using a hyperbolic function being
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the Trp emission spectrum was observed.
2.7. Calcein leakage
Calcein-containing LUVs were made using the same protocol used
to make regular LUVs, except for the hydration step made with Tris
buffer of the lipid ﬁlms, which contained 70 mM calcein [30]. Free
calcein was separated from the calcein-containing LUVs using size
exclusion column chromatography (Sephadex G-75) with Tris as elution
buffer. The concentration of lipids was estimated using Rouser protocol
[31]. For the assay, the lipid concentration was set at 1 μM and peptide
concentration was allowed to vary from 1 nM to 500 nM (P/L ratio of
1/1000 to 1/2 respectively). All measurements were performed with a
Perkin Elmer LS55 spectrometer (Buckinghamshire, UK). Data were
collected every 1 s at room temperature using a λexc at 485 nm and
λem at 515 nmwith an emission and excitation slit of 2.5 nm in a cuvette
of 2 mL.
The ﬂuorescence from calcein at 70 mM concentration was low
due to self-quenching, but increased considerably upon dilution.
The ﬂuorescence intensity at the equilibrium was measured after
2.5 h. At the end of the assay, complete leakage of LUVs was achieved
by adding 100 μL of 10% Triton X-100 solution dissolving the lipid
membrane without interfering with the ﬂuorescence signal. The per-
centage of calcein release was calculated according to the following
equation:
%Calcein leakage ¼ Ft–Foð Þ= Ff–Foð Þ100 ð1Þ
where the percent of calcein leakage is the fraction of dye released
(normalized membrane leakage), Ft is the measured ﬂuorescence in-
tensity at time t, and Fo and Ff are respectively the ﬂuorescence intensi-
ties at times t=0, and after ﬁnal addition of Triton X-100, respectively.
A dilution correction was applied on the ﬂuorescence intensity after in-
jection of the Triton X-100. Each experiment was repeated three times.
2.8. 31P Nuclear Magnetic Resonance (31P NMR)
MLVs were prepared as described in Section 2.3 at a concentration
of 150 mg/mL in D2O/H2O (90:10) and NMR acquisition was
performed in a rotor of 100 μL. The peptide was added as a powder to
the liposomes to obtain a P/L ratio of 1/100 and then thoroughly vortexed
to ensure sample equilibrium. NMR experiments were carried out on a
Bruker Advance DPX 400 NB spectrometer by the mean of a QNP-Probe
(1H/31P–13C–19F). 31P NMR spectra were acquired at 161.97 MHz, using
a phase-cycled Hahn-echo pulse sequence with gated broadband proton
decoupling. Typical acquisition parameters were as follows: spectral
window of 50 kHz, π/2 pulse widths of 14 μs, interpulse delays of
50 μs, a recycle delay of 5 s, 128 scans were recorded and a scanning of
temperature from 2 to 20 °C was applied. A line broadening of 50 Hz
and baseline correction was usually applied prior to Fourier transforma-
tion. The amount of each phase (lamellar, hexagonal and isotropic
phases) was determined by simulation of the experimental spectrum
[32] (T. Pott and E.J. Dufourc, unpublished data).
2.9. Circular dichroism (CD)
CD data was recorded on a Jasco J-815 CD spectrophotometer with
a 1 mmpath length. Far-UV spectra were recorded from 180 to 270 nm
with a 0.5 nm step resolution and a 2 nm bandwidth at 37 °C. The scan
speedwas 50 nm/min (0.5 s response time), and the spectrawere aver-
aged over 8 scans. CD spectra were collected for samples of RW16 in
phosphate buffer with and without liposomes at different P/L ratios
(1/100, 1/50, 1/25, 1/10). For each sample, the background (buffer)
was automatically subtracted from the signal. Spectra were smoothed
using a Savitzky–Golay smoothing ﬁlter. Spectra were deconvolutedusing the software CD Friend previously developed in our laboratory
(S. Buchoux, unpublished).
2.10. Plasmon Waveguide Resonance (PWR)
PWR spectra are produced by resonance excitation of conduction
electron oscillations (plasmons) by light from a polarized CW laser
(He–Ne; wavelength of 632.8 and 543.5 nm) incident on the back
surface of a thin metal ﬁlm (Ag), deposited on a glass prism and coated
with a layer of SiO2. Experimentswere performed on a beta PWR instru-
ment from Proterion Corp. (Piscataway, NJ) that had a spectral angular
resolution of 1 mdeg. PWR spectra, corresponding to plots of reﬂected
light intensity versus incident angle, can be excited with light
whose electric vector is either parallel (s-polarization) or perpendicular
(p-polarization) to the plane of the resonator surface.
The sample to be analyzed (a lipid bilayer membrane) was
immobilized on the resonator surface and placed in contactwith an aque-
ous medium, into which drugs can be introduced. The self-assembled
lipid bilayers were formed using a solution (in butanol/squalene
95/5 v/v) of 10 mg/mL of lipids. The method used to make the lipid
bilayers is based on the procedure by Mueller and Rudin to make
black lipid membranes across a small hole in a Teﬂon block [33]. To
accomplish this, a small amount (~2.5 μL) of lipid solution was
injected into the oriﬁce in a Teﬂon block separating the silica surface
of the PWR resonator from the aqueous phase. Spontaneous bilayer
formation was initiated when the sample compartment was ﬁlled with
aqueous buffer solution. Themolecules (such as lipids anddrugs) depos-
ited onto the surface plasmon resonator change the resonance charac-
teristics of the plasmon formation and can thereby be detected and
characterized (for more details see [34]). The peptide was injected into
the cell sample compartment containing the lipid membrane in an
incremental fashion. The amount of lipid bound drug is associated
with the resonance shift observed by PWR, the total amount being the
amount of drug added to the chamber. Since the PWR is only sensitive
to the optical properties of material that is deposited on the resonator
surface, there is no interference from the material that is in the bulk
solution. Moreover, the amount of bound material is much smaller
than the total amount of peptide present in the bulk solution, and it is
assumed that the bulk material is able to freely diffuse and equilibrate
with themembrane. Datawere ﬁtted (GraphPad Prism) through the fol-
lowing hyperbolic function that describes the binding of a ligand to a
receptor, providing the dissociation constants: Y=(Bmax X)/(Kd+X).
Bmax represents the maximum concentration bound, and Kd is the
concentration of ligand required to reach half-maximal binding [35]. It
should be noted that since concomitantly with the binding process
other processes, such as membrane reorganization and solvation occur,
the dissociation constants correspond to apparent dissociation constants.
Graphical analysis allows one to obtain information about changes in the
mass density, structural asymmetry, and molecular orientation induced
by bimolecular interactions occurring at the resonator surface. By plotting
the spectral changes observed in a (s, p) coordinate system where mass
(Δm) and anisotropy (Δstr) axes are represented based on the PWR
sensitivity factor, the contribution of mass and structural changes can
be obtained [36,37]. Each point in the mass and anisotropy axis can be
expressed by changes in the original coordinates (Δp and Δs) by the
following equations:
Δm ¼ Δsð Þ2m þ Δpð Þ2m
h i1=2 ð2Þ
Δstr ¼ Δsð Þ2str þ Δpð Þ2str
h i1=2 ð3Þ
The sensitivity factor (Sf), a measure of the sensitivity of the instru-
ment for the s-polarization relative to p-polarization (Sf=Δs/Δp), nec-
essary to determine themass and anisotropy axes has been determined,
for the prism used in those experiments, to be 0.74 [38].
Table 1
Antimicrobial and lytic activities of RW16.a Results are the mean of three independent
experiments each performed in duplicate.
Peptide E. coli S. aureus K. pneumoniae
RW16 10 μMb 5 μMc >100 μM
a The antimicrobial activity is expressed as MIC (μM), the minimal peptide concen-
tration required for total inhibition of cell growth in liquid medium.
b Lytic effect observed at this concentration.
c No lytic effect observed at this concentration.
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Microcalorimetry experiments were performed with a Nano DSC-II
microcalorimeter (CSC) driven by a DSC-run software. The peptide
was gradually added to the same sample of lipid MLVs to obtain pep-
tide/lipid molar ratios of 1/100, 1/50 and 1/25. The lipid concentration
was 1 mg/mL (ca. 1.45 mM), except for: DMPG/DPPC where the con-
centration was 4 mg/mL (ca. 5.66 mM), DMPC/Chol and DMPG/Chol
where the concentration was 6 mg/mL (ca. 8.9 and 9.05 mM respec-
tively). For each peptide concentration, a minimum of four heating
and four cooling scans were performed so that equilibrium is reached.
A scan rate of 1 °C/min was used and there was a delay of 10 min
between sequential scans in a series to allow thermal equilibration.
Data analysis was performed by the ﬁtting program CPCALC provided
by CSC and using the Software Origin for the deconvolution.
2.12. Isothermal Titration Calorimetry (ITC)
ITC experiments were performed on a Microcal ITC200 at different
temperatures between 15 and 40 °C. To avoid air bubbles, peptide
and LUV solutions were degassed under vacuum before use. Titrations
were performed by injecting 2.5 μL aliquots of LUVs (lipid concentra-
tion 12.6 mM in a syringe of 40 μL) into the calorimeter cell of 200 μL
containing the peptide solution (peptide concentration 0.1 mM), with
10 min waiting between injections. A blank was performed where the
LUVs were titrated into the same buffer used for the above experiments
(Tris buffer). Data analysis was performed using the programOrigin 7.0
microCal. All curves were ﬁt using a nonlinear least-squares “One Set of
Sites” (1∶1 interactions) model.
2.13. Cryo-Transmission Electronic Microscopy (Cryo-TEM)
RW16 was mixed with DOPC or DOPG LUVs (1 mM) in Tris buffer
for a ﬁnal peptide concentration of 40 μM (P/L ratio of 1/25). After 1 h
incubation, a 5 μL sample was deposited onto a lacey carbon cupper
grid (Ted pella) placed in the automated device for plunge-freezing
(EM GP Leica) enabling a perfect control of temperature (15 °C) and
relative humidity (70%). The excess of sample was blotted with
ﬁlter paper and the grid was plunged into a liquid ethane bath
cooled and maintained at −183 °C with liquid nitrogen. Specimens
were maintained at a temperature of approximately−170 °C, using a
cryo holder (Gatan, CA, USA) and observed with a FEI Tecnai F20 elec-
tron microscope operating at 200 kV and at nominal magniﬁcations of
19,000× or 50,000× under low-dose conditions. Images were recorded
with a 2k×2k USC 1000 slow-scan CCD camera (Gatan) and analyzed
using ImageJ.
3. Results and discussion
The choice in terms of the model membrane lipid composition
used in each experiment has taken into account several aspects among
which the typical composition of the cell membrane to mimic and the
limitations of the technique employed. Eukaryotic cell membranes con-
tain essentially zwitterionic lipids such as phosphatidylcholine lipids
(PC) so this kind of lipid was used to mimic those cells. Several studies
have shown that the cell membrane composition changes in cancer
cells with overexpression of certain types of proteoglycans and the
enrichment in the outer leaﬂet of negatively charged lipids (such as
phosphatidylserine, PS) [15,16,18,19]. Therefore, overall cancer cells
possess a more negatively charged membrane than normal cells. In
view of the potential of RW16 in decreasing the motility (migration
speed, random motility coefﬁcient, wound healing) of the tumor cells
and its intracellular actin-remodeling activity [10], the study of the
interaction of this peptide with membranes mimicking cancer cells is
of interest. Tomimic the cancer cellmembrane negatively charged lipids
such as phosphatidylglycerol (PG) and PS were used in the presentstudies. Additionally bacterial membranes are rich in negatively charged
lipids such as PG and as will be presented below RW16 as antimicrobial
activity. Depending on the limitations of each technique, the fatty acid
chain length and degree of unsaturation was chosen accordingly.
3.1. Antimicrobial activity
The antibacterial activity of RW16was assayed against Gram-negative
and Gram-positive bacteria (Table 1). RW16 inhibited the growth of both
Gram-positive and Gram-negative bacteria with minimal inhibitory con-
centrations in the low micromolar range. It is interesting to note that for
peptide concentrations around the MIC value in the case of S. aureus,
the bacteria appeared non-homogeneously dispersed in the plate being
agglomerated in certain regions. This was not observed for the other
two bacterial strains investigated. For E. coli and S. aureus, the lytic activity
of RW16 was tested by incubating bacteria overnight with a RW16 con-
centration corresponding to the MIC. No colony-forming units appeared
in the case of E. coli, indicating that RW16 is bactericidal. In the case of
S. aureus, the bacteria were able to re-grow after being incubated with
RW16 at theMIC concentration, demonstrating the bacteriostatic activ-
ity of RW16 on this bacterial strain.
3.2. Peptide effect on turbidity and homogeneity of membrane models
Turbidity experiments (Fig. 1) followed absorbance changes at
436 nm of vesicle suspensions of DOPC, DOPE, DOPG and DOPS
LUVs upon gradual addition of RW16.We have observed that addition
of peptide to zwitterionic (DOPC or DOPE) LUVs caused no changes in
turbidity, whereas they lead to a massive increase in the turbidity of
DOPG or DOPS LUVs indicating that vesicle aggregation occurred. This
result shows that electrostatic interactions between negative charges
of anionic membranes and the positive charges of RW16 (10 positive
charges at pH 7) are inducing liposome aggregation. These results are
not surprising since it has already been shown that cationic CPPs inter-
act preferentially with negatively charged membrane [21,39–42].
When kinetic experimentswere performed after the initial aggregation,
a slow decrease in turbidity was observed after 3 min incubation (data
not shown). This goes along the lines of a dissociation of the liposome
aggregates with time, after the initial aggregation, rather than their
fusion.
We also monitored the size of liposomes, following addition of
peptide, by DLS to further understand the observed changes in LUVs
turbidity (Table 2). We performed DLS experiments on RW16 alone
to investigate whether the peptide auto-associates or not. In this
case we have observed that below a concentration of 5 nM the size
of the scattering particles was too small to be detectable but above this
concentration the size rapidly increases to form objects with a size be-
tween90 and170 nm(data not shown). This indicates that RW16 rapidly
forms oligomers at very low concentrations (concentrations comprised
between 1 nM and 5 nM) probably due to high hydrophobic interactions
between the Trp. RW16being an amphipathic peptide, its autoassociation
is expected and indeedwas shownhere to occur below a concentration of
5 nM. The experimental setup being different for each method used, the
peptidewas in themonomer form in some studies (PWR, calcein leakage)
while in others was in oligomeric form (ITC, DSC, NMR, CD, Trp ﬂuores-
cence). This aspect is important when analyzing the results as the nature
Fig. 1. Turbidity measurements of LUVs composed of DOPC, DOPE, DOPG and DOPS (all
at 1 mg/mL in Tris buffer) following RW16 incremental addition (P/L ratios of 1/100, 1/50,
1/25 and 1/10 corresponding to 12.5 μM, 25 μM, 50 μM and 125 μM respectively). The
experiments were performed in duplicate.
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monomeric form of the peptide has both hydrophobic and hydrophilic
surfaces exposed. Peptide autoassociation should occur through the
hydrophobic face, so the oligomer will have a hydrophobic core (mostly
not accessible) and a hydrophilic available surface. In fact, ﬂuorescence
experiments were performed to compare the λmax of RW16 with that of
penetratin, a peptide that has not been shown to oligomerize. The λmax
of the Trp ﬂuorescence of RW16 alone was slightly shifted (347 nm)
compared to that of the penetratin alone (350 nm, data not shown).
DLS experiments on liposomes show that DOPC vesicle size did
not change upon peptide addition. In the case of DOPE LUVs the poly-
dispersity index was too high to be able to exploit the data but it seems
that larger or different objects were formed. This could be due to the
propensity of PE to form inverted micelles as it has been observed by
Seddon [43]. In the case of DOPS and DOPG LUVs, a signiﬁcant increase
of the liposome size that could reach about 1 μm of hydrodynamic
radius was observed. Measurements were taken immediately after
peptide addition to liposomes and an increase in the solution turbidity
was seen right away. After several days, a lipid deposit at the bottom
of the tubes was formed. Thereby, one can assume that electrostatic
interactions between the peptide and the lipid play an important role
in liposome behavior in terms of homogeneity and aggregation. Similar
behavior was observed in the case of RL16, a peptide with the sameTable 2
Vesicle size distribution from Dynamic Light Scattering measurements of LUVs composed
of DOPC, DOPE, DOPS and DOPG expressed as the hydrodynamic diameter (nm). The lipid
concentrationwas 1 mg/mL towhich peptidewas gradually added. The experiments have
been done in duplicate at room temperature.
P/L ratio DOPC DOPE DOPS DOPG
0 120±10 145±15 115±5 120±10
1/100 122±12 267±107a 121±11 133±19
1/50 116±6 472±252a 140±30 261±100a
1/25 121±11 757±7 141±31 302±64a
1/10 125±15 759±440a 1235±565a 1244±284a
a The error bars were too important to establish an exact size of the liposomes.sequence but with Leu residues instead of Trp [21]. Other CPPs such as
penetratin, and arginine-rich peptides as well as antimicrobial pep-
tides which also possess a great amount of positively charged resi-
dues also show important electrostatic interactions with anionic
lipids [21,39–42,44]. From the data we cannot yet predict whether the
larger objects observed arise from liposome aggregation or fusion.
To better understand the peculiar behavior of PE liposomes in the
presence of the peptide (no changes in turbidity but increase in particle
sizes), we have performed 31P NMR on DOPE MLVs in the absence or
presence of RW16 (Figs. 2 and S2). The peptide was added to the lipo-
somes at a P/L ratio of 1/100 and temperature was scanned from 2 to
20 °C. We have observed that the transition from the lamellar phase
(Lα) to the hexagonal type II phase (HII) occurred at 7.1 °C±0.4 °C
and in the presence of RW16 at 11.1 °C±0.4 °C. This result shows
that the peptide stabilizes the lamellar phase, which could be explained
by an intercalation of the peptide between the lipid polar headgroups
without insertion into the bilayer core. This location would counteract
the natural effect of PE lipids to induce a local negative curvature
prompting for hexagonal type II phases. It also appears that the peptide
promotes a small percentage of isotropic phases (sharp peak centered
at 0 ppm). This would suggest that the RW16 peptide promotes in
addition a limited, but detectable, membrane restructuration with ap-
pearance of μm-sizedMLVs. To conclude RW16 interacts, in a moderate
way, with PE lipids.Fig. 2. (A) Percentages of lamellar (Lα), hexagonal type II (HII) and isotropic (Iso)
phases of DOPE as a function of the temperature in the absence (ﬁlled symbols) and
presence (empty symbols) of 1/100 of RW16 (2 mM). The points were ﬁtted through
a sigmoidal curve. (B) First derivative of the percentages of lipid phases represented
in A in the absence (solid line) and presence (dashed line) of RW16 at P/L 1/100.
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The interaction of RW16 with phospholipids was studied by mon-
itoring the way this peptide affects the Lβ gel phase to the Pβ′ ripple
phase (pre-transition temperature, Tpre) and the Pβ′ ripple phase to
the Lα liquid phase (main transition temperature, Tm) transitions of
different lipids. Indeed, the phase transition temperature and ther-
modynamics of lipid phase transitions are extremely sensitive to the
presence of exogenously added compounds. Herein, we have chosen
to use C14 fatty acyl chain lipids as their phase transition is close to
room temperature, which facilitates handling (reason why they are
often used in DSC studies, despite their absence in cell membranes).
The experiments were performed with MLVs rather than other type of
vesicles becauseMLVs give a highermagnitude andmore homogeneous
signal in DSC [45]. DSC heating endotherms illustrating the effect of
RW16 on MLVs of DMPC, DMPC/Chol (95:5), DMPG, DMPG/Chol (95:5),
DMPG/DPPC (60:40) are presented in Fig. 3 and the thermodynamic
parameters obtained from these experiments are presented in Table 3.
Vesicles of DMPC exhibit two endothermic events, a less energetic
pre-transition near 14 °C that arises from the conversion of the Lβ to
the Pβ′ phase and amore energeticmain transition from the conversion
of Pβ′ to Lα phase around 24 °C. In interaction with DMPC (Fig. 3A,
Table 3) the peptide decreases the pre-transition enthalpy (ΔHpre)
starting from very low concentrations (P/L=1/100). This decrease in
the pre-transition enthalpy arises from a modiﬁcation in the tilting of
the lipid polar headgroups and shows an interaction between the pep-
tide and the lipid polar headgroups. As for the main transition, RW16Fig. 3. DSC thermograms illustrating the effect of the addition of increasing concentrations o
DMPG/Chol (95:5) (E) vesicles.does not signiﬁcantly change the Tm but reduces the main transition
enthalpy (ΔHm) and increases the ΔT1/2. A change in ΔHm is the conse-
quence of the disruption of van der Waals interactions between the
hydrocarbon chains. It shows that the peptide is able to intercalate be-
tween the fatty acid chains reducing the cooperativity of the transition
(reﬂected in the increase of the ΔT1/2).
In terms of the pre-transition, RW16 affects strongly that of DMPG
than DMPC, as it completely abolishes it, starting at very low concen-
trations (P/L=1/100) (Fig. 3B, Table 3). This may be a consequence of
the more favorable electrostatic interaction between the negatively
charged lipid headgroup and the positive charges in the peptide. At
increasing concentrations of peptide we have observed a splitting of
the main transition peak which has been suggested in the literature to
arise from the coexistence of peptide-rich and peptide-poor domains in
the bilayer [46,47]. We have observed an increase of the ΔT1/2 which
arises from a decrease of the cooperativity of the hydrocarbon chains
due to the insertion of the peptide in the lipids.
While the role of electrostatics could be studied by just comparing
the effect of the peptide on zwitterionic vs anionic lipid membranes
(using single lipid liposomes), binary lipid mixtures containing
lipids with sufﬁciently different phase transition temperatures have
been used to evaluate the possible lipid recruitment induced by the
peptide [48–50]. Herein we have worked with vesicles composed of
DMPG/DPPC (60:40). We have to remind that the Tm of DMPG and
DPPC are 24 °C and 41 °C, respectively. As presented in Fig. 3C the bina-
ry mixture presents a Tpre around 19.1 °C and a Tm around 30.9 °C. In
interaction with these vesicles the peptide induces a splitting of thef peptide to DMPC (A), DMPG (B), DMPG/DPPC (60:40) (C), DMPC/Chol (95:5) (D) and
Table 3
Thermodynamic parameters obtained with DSC experiments. For all experiments at least 4 scans were done in order to attain thermodynamic equilibrium. Two values indicate a
splitting of the signal.
Pre-transition Main transition
Tpre (°C) ΔH (kcal/mol) ΔS (cal/K/mol) ΔT1/2 (°C) Tm (°C) ΔH (kcal/mol) ΔS (cal/K/mol) ΔT1/2 (°C)
DMPC Lipid 14.2 1.4 3 2 23.8 8.7 29 0.5
1/100 RW16 12.7 0.6 2 2.6 23.7 6.2 21 0.8
1/50 RW16 12.8 0.5 2 2.5 23.7 5.4 24 0.8
1/25 RW16 12.9 0.1 0 3 23.7/26.5 2.9/2.5 9.8/8.3 2.2/4.2
DMPG Lipid 14.3 0.3 1 3 23.8 6 20 1.5
1/100 RW16 – – – – 21.5/24.1 0.6/4.8 2/16 1.4/2.3
1/50 RW16 – – – – 21.6/24.8 2.2/4.4 7.5/15 1.5/4.2
1/25 RW16 – – – – 21.4/25 1.3/3.7 4.4/12 1.5/5.2
DMPG/DPPC (60:40) Lipid 19.1 0.4 1 5.5 30.9 9 30 3.8
1/100 RW16 – – – – 32.2 6.5 21 6.9
1/50 RW16 – – – – 32.9/36.4 4.4/2.3 14/11 6.7/2.8
1/25 RW16 – – – – 34/38.4 2.82/2.13 9.2/6.8 5.94/2.97
DMPC/Chol (95:5) Lipid – – – – 21.2/24.9 3.4/2.7 12/9.1 1.8/7.1
1/100 RW16 – – – – 21.1/25.8 0.7/6.2 2.4/21 1.4/10.9
1/50 RW16 – – – – 25.6/31.6 1.8/0.6 6/2 7.3/7.1
1/25 RW16 – – – – 27.3 3.5 12 22.9
DMPG/Chol (95:5) Lipid 13.6 nd nd nd 22.4 5.8 20 1.9
1/100 RW16 – – – – 22.4/18 3.9/1.3 13/4.4 3.4/2.6
1/50 RW16 – – – – 23.2/17.3 4.1/2 14/6.9 8.6/2.2
1/25 RW16 – – – – 23.8/16.9 3.4/0.5 11/1.7 12.5/1.9
– The transition was not observed.
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temperatures when increasing concentrations of peptides are added
approaching the main transition of the DPPC (41 °C). This means that
the peptide leads to the segregation of DPPC from the lipid mixture.
Consequently the other peak, observed at a lower temperature, corre-
sponds to the peptide-perturbed phase transition of DMPG. Since
the Tm of the DMPG-rich component is further away from the Tm of
DMPG pure (about 10 °C difference for P/L 1/25) than that of the
DPPC-rich component from DPPC pure (less than 2 °C of difference for
P/L 1/25), theDMPG-rich component ismore affected, somore enriched
in peptide. One should note that each lipid-rich component is not
expected to possess a Tm exactly similar to the Tm of its main lipid com-
ponent (even if no peptide is affecting its transition), this is because
each component is not purely composed of its main lipid as there is
always some of the other lipid component mixed. The data points to a
preferential interaction of RW16 with a domain rich in DMPG and a
segregation of a DPPC rich component. The driving force behind this
peptide preference for DMPG might be either electrostatic and/or the
greater ﬂuidity of this lipid as we have observed in previous studies,
where the preferential peptide interaction occurred with the lipids
possessing lower Tm [51]. Studies by other laboratories using DSC
have also shown a preferential interaction of a peptide with one lipid
component in a binary mixture and the consequent segregation of the
other component [48–50].
When cholesterol is present in the DMPC vesicles (5%) the
pre-transition is not observable (Fig. 3D, Table 3). Indeed cholesterol,
by ﬂuidifying the membrane, highly decreases the enthalpy of the
phase transition abolishing the pre-transition signal and highly broaden-
ing the main transition. The main transition peak (around 21.2 °C) is
splitted when the peptide is added, the enthalpy highly decreases and
the ΔT1/2 highly increases. In the presence of cholesterol (DMPC/Chol
95/5%mol/mol) the decrease in enthalpy is considerablymore important
than in the case of DMPC vesicles (we have observed a decrease in en-
thalpy of 80% with DMPC/Chol and 46% with DMPC alone). The higher
decrease in the cooperativity of the main transition observed in the
presence of cholesterol shows that the peptide affects more the fatty
acid chain packing in the presence of cholesterol. This suggests that
cholesterol, by inducing the formation of a liquid ordered phase (Lo)
in the membrane, improves peptide insertion into the bilayer. In the
case of DMPG/Chol (95/5% mol/mol) vesicles, the behavior of the lipids
with increasing concentrations of peptide is practically the same as thatobserved for DMPG alone (both in terms of enthalpy and cooperativity
of the transition) (Fig. 3E). The fact that the presence of cholesterol does
not change the mode of interaction of RW16 with anionic lipids sug-
gests that the peptide penetrates less deep in the fatty acid chain region
in the presence of anionic lipids vs zwitterionic ones.
The membrane perturbation effect of the peptide was then investi-
gated by calcein leakage experiments. LUVs composed of DOPC, DOPG
and DOPC/DOPG (8:2) were used and P/L ratios in the range of 1/1000
to 1/10. Smaller P/L ratios were used here (P/L 1/1000) compared to
other experiments (usually the smallest P/L ratio was 1/100) because
calcein leakage started to occur at very low concentrations. Contrarily
to previous experiments, here lipids with C18:1 fatty acid chains were
used to ensure that lipids were in the ﬂuid phase at room temperature
(the Tm of these lipids is inferior to 0 °C). For this kind of experiments if
lipids are in the gel phase the calcein leaks automatically due to the
rigidity and defects of the bilayer. In the absence of RW16 a low ﬂuores-
cence signal was observed due to calcein self-quenching inside the lipo-
somes, no leakage from liposomes occurred under these conditions
(Fig. 4A). Kinetic experiments show that RW16 leads to a very fast
leakage that occurs in a matter of seconds and that saturates in
about 2 h (P/L ratio 1/25, Fig. 4A, Ft).When the peptidewas incremental-
ly added toDOPC LUVs a strong increase in the percentage of calcein leak-
agewas observed starting from very low P/L ratio (1/1000). Additionally,
the signal saturated at very low peptide concentration (~20 nM, P/L ratio
1/50) (Fig. 4B). When monitoring the changes in calcein leakage using
different peptide concentrations, one can see that leakage started to
occur at very low concentrations of RW16 (1 nM) and that it rapidly
reached saturation (with a leakage of ~75%) for a concentration of
peptide of 40 nM (which corresponds to P/L=1/25). The plot was ﬁtted
through a hyperbolic curve allowing determination of a half maximum
activity of 3.2±0.7 nM. The leakage process seems to be cooperative, as
it has already been observed by other laboratories. Indeed it has been
shown that cooperative insertion of the peptide could occur. This peptide
insertion (only fewpeptidemolecules are sufﬁcient)would create amass
imbalance and membrane destabilization [52]. This mass imbalance has
also been demonstrated using molecular dynamics simulations as a
mechanism responsible for strong membrane perturbation leading to
formation of membrane defects [53–55].
The calcein leakage behavior of DOPG liposomes is more compli-
cated to analyze. While at low concentrations (up to 40 nM that cor-
responds to a P/L of 1/25) there is less leakage than with DOPC and
Fig. 4. (A) Typical ﬂuorescence measurements for a calcein leakage experiment. The
peptide is added (in this case with a P/L ratio of 1/25) to LUVs after ~10 min to
check any basal leakage (Fo) and Triton X100 is added at the end of the measurement
(Ff), that is after ~2.5 h to obtain themaximum liposome leakage (Ft). (B) Calcein leakage
fromDOPC (black), DOPG (dark gray) and DOPC/DOPG (80:20) LUVs (gray) upon peptide
addition in the range 0–100 nM. All data were ﬁtted using a hyperbolic curve, except in
the case of DOPG where a two phases ﬁt (hyperbolic and linear) was performed. Error
bars mean SEM on at least 3 experiments.
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concentrations (above P/L 1/25) the response is linear and strong
leakage is observed. This data has to be taken with caution as it has
been observed byDLS and turbidity that strong perturbations in anionic
liposomes size occur at high P/L ratios with aggregation of objects.
When the vesicles were composed of DOPC/DOPG (8:2) the proﬁle of
the curve is very similar to that of DOPG at low peptide concentrations
indicating that the peptide is ﬁrst interacting with anionic lipids in a
cooperativity manner. Once all the anionic lipids are occupied, the pep-
tide interacts with zwitterionic lipids always in a cooperativity manner
as observed in the case of DOPC alone. The percentage of leakage is
similar to that of DOPG at low concentrations. This interpretation agrees
well with that proposed in the DSC experiments on DMPG/DPPC LUVs
(Fig. 3C, Table 3) and reinforces the anionic lipid segregation theory.
Furthermore it could suggest that the higher the complexity of lipid
model composition, the less they are susceptible to perturbation com-
pared to model membranes composed of single lipids. Although these
effects may partly be due to speciﬁc interactions between the peptides
and the phospholipid headgroups, they also suggest a competitionbetween electrostatic and hydrophobic forces. For a bilayer consisting
of zwitterionic phospholipids, these peptides could possibly be inserted
more deeply into the hydrophobic part of the bilayer (through the
hydrophobic peptide face containing the Trp residues) causing an
important leakage. In the case of negatively charged lipids, the electro-
static attraction between the peptide and the lipid (in this case the
charged peptide face would be facing the lipid headgroups) could
“immobilize” the peptide in the lipid headgroup region inhibiting a
deeper insertion. Similar observations have previously been reported
for the bee venom melittin [56].
3.4. Peptide afﬁnity for the membrane
The afﬁnity of RW16 for bilayers purely zwitterionic or composed
of both anionic and zwitterionic lipids (eggPC/POPG and DOPC/DOPS)
was studied by PWR (Fig. 5) and the resulting dissociation constants are
presented in Table 4. Successive aliquots of RW16 solutionswere added
to the sample compartment of a PWRcell containing preformedbilayers
composed of each of the different lipids used in these experiments. The
signals observed before and after bilayer formation and upon saturating
concentrations of peptide for p- and s-polarization are presented in
Fig. 5 panels A and B, respectively. From these spectra we can get differ-
ent information relative to the systemdeposited on the prism surface by
analyzing the shift of the minimum of reﬂectance as a function of con-
centration or by ﬁtting the spectra to obtain the optical parameters
(for more details, see [57]). In all cases, PWR spectral changes were
observed upon peptide addition to the membrane, indicating peptide
interaction with the bilayers. In our case when the peptide is added to
the bilayer we have observed a decrease in the mass of the system (as
the angle of resonance decreases for both polarizations, Δαb0) and a
decrease of the thickness of the system (as the spectral depth decreases,
ΔRb0). A simple molecular interaction should lead to an increase in
the resonance angle position as an increase in mass is produced by the
interaction of additional molecules with the prism surface (increase in
the refractive index). When this is not the case, it means that the
peptide leads to a reorganization of the bilayer resulting in removal of
part of the lipid mass from the membrane. Two explanations are possi-
ble for this scenario: the peptide has a detergent effect on the mem-
brane, solubilizing part of the bilayer or the peptide leads to changes
in the lipid properties resulting in a higher surface area occupied by
each lipid molecule (and so a reduced mass per surface). At this stage
it is not possible to distinguish between the two explanations.
A typical plot of the resonance angle changes for p- and s-polarization
as a function of added concentrations of RW16 for an eggPC bilayer is
shown in Fig. 5C. These points can be ﬁtted through a hyperbolic function
indicating that saturable binding occurred. Apparent dissociation con-
stants are presented in Table 4. As mentioned above this experiment
was conducted in bilayers purely zwitterionic and containing also anionic
lipids. In all cases, RW16 induced shifts to smaller angles, indicating that
in all cases a reorganization of the membrane occurred with a decrease
in the mass of the system. Using Eqs. (2) and (3), the contributions of
a pure mass effect and a pure structural effect to the spectra were calcu-
lated, indicating that mass changes accounted for 80–100% of the spec-
tral changes (~100% in the case of eggPC and DOPC bilayers and
~90% and ~80% in the case of a mixture of DOPC/DOPS or eggPC/POPG
bilayers, respectively). As for our surprise, the afﬁnity constants
obtained show that the afﬁnity of RW16 for the lipids is mostly not
affected by the lipid composition, being always in the low nM range. It
is interesting to note that these values correlate very well with those
obtained in calcein leakage experiments. Therefore, the dissociation
constants observed by PWR reﬂect mostly the membrane perturbation
exerted by the peptide on the membrane (pore formation or partial
membrane disruption) rather than a simple membrane recognition
(such as an electrostatic interaction between the positively charged
amino acids in the peptide and the negatively lipid headgroups) which
explains the lack of lipid speciﬁcity in the interactions. A decrease in
Fig. 5. Interaction of RW16 with an eggPC bilayer monitored by PWR. Panels A and B correspond to the PWR spectra obtained for the buffer (■), for the lipid bilayer (○) and after
addition of 0.3 μM of RW16 to the bilayer (●) obtained for p- and s-polarized light, respectively. Experiments were performed with a spectral angular resolution of 1 mdeg. The
shifts in the minimum of resonance upon incremental addition of peptide are presented in panel C for an eggPC bilayer. The points were ﬁtted through a hyperbolic curve.
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be a common way of membrane destabilization by several membrane
active peptides [58,59].
The afﬁnity of RW16 to DOPG and DOPC LUVs was studied using
Isothermal Titration Calorimetry. In these experiments RW16 solu-
tion (0.1 mM) was titrated with LUV solution (12.6 mM) and gradual
injections were realized with 10 min interval between each injection
to allow equilibrium. When DOPC vesicles were used no signal was
observed (no heat exchange was developed for each injection; data
not shown) contrarily to DOPG LUVs where a well deﬁned exothermic
signal was observed (Fig. 6A and B). An afﬁnity in the micromolar
range was determined from this data (Fig. 6, Table 5). The experiments
have been done at different temperatures in order to determine the var-
iation in theheat capacity (ΔCp, obtained from the slope of the linearﬁt)Table 4
Dissociation constants of RW16 for different lipid bilayers as determined by PWR. The
experiments have been done at least three times.
p-Polarization (nM) s-Polarization (nM)
EggPC 1±0.3 1.4±0.4
EggPC/POPG 1.08±0.3 0.6±0.3
DOPC 1.68±0.4 2.15±0.6
DOPC/DOPS 2.2±0.6 1.2±0.5that reveals important information regarding the nature of the peptide/
lipid interactions. The temperature dependence of ΔH is represented in
Fig. 6C. The ΔCp is the sum of two terms resulting from the release of
water from the hydrophilic and hydrophobic regions of the bilayer.
When the ΔCp>0 typical of electrostatic interactions, the enthalpy is
“favorable”, and when the ΔCpb0 the interaction is “entropy driven”
and this is typical of hydrophobic interactions which means a transfer
of a molecule from a polar to a nonpolar environment. The ΔCp
observed is negative (−42 kcal/mol/K) indicating that dehydration of
hydrophobic regions of the bilayer is occurring during peptide interac-
tion, hydrophobic interactions occupying an important role [60]. This
correlates well with PWR results that have shown that the afﬁnity of
the peptide for lipids is not driven by the lipid charges. We have
observed that the stoichiometry (n) increases with the temperature.
We hypothesized this to be due to a decrease in the oligomerization
state of the peptide at increasing temperatures (peptide dissociation).
One important aspect to note concerns the difference in the binding
afﬁnity range observed in the different experiments (in the nanomolar
range with PWR and calcein leakage experiments and in the micromo-
lar range with ITC experiments). We are most certain that the disparity
in these results arises from the different experimental conditions used,
more speciﬁcally concerning peptide concentration and thus peptide
oligomerization state. As the DLS studies show, RW16 behavior (in the
absence of lipid) changes depending on its concentration, with peptide
autoassociation occurring around 5 nM. In PWR and calcein leakage
Fig. 6. Titration of the peptide solution (0.1 mM) with 2.5 μL aliquots of DOPG LUVs
(12.6 mM) (A) and the corresponding integrated signals (B) for a temperature of 20 °C.
The temperature dependence of the binding enthalpy for the interaction between DOPG
LUVs and RW16 is presented panel C. The ΔCp corresponds to the slope of the linear ﬁt.
Table 5
Thermodynamic parameters obtained from the ITC experiments. The solution of
peptide (0.1 mM) was titrated with the solution of DOPG liposomes (12.7 mM). The
experiments have been performed at different temperatures and averaged over two
experiments.
T (°C) n Kd (μM) ΔH (cal/mol) ΔS (cal/mol/°C) ΔG (cal/mol)
20 2.32 1.7 −2866 16.6 −3198
25 3.4 1.3 −3004 16.8 −3424
30 3.7 6.7 −2892 14.1 −3315
35 6.8 2.7 −3403 14.4 −3907
40 6.7 18 −3976 9.02 −4337
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peptide concentrations (the peptide being in the monomer form)
whereas in the ITC experiments the liposomes are added to the peptide
that is at 0.1 mM so already auto-associated. While at low peptide con-
centrations, the peptide has both faces (hydrophilic and hydrophobic)
exposed for lipid interaction and can therefore interact with both zwit-
terionic and anionic lipids with increased afﬁnity (as observed in PWR
studies), at higher peptide concentrations the peptide hydrophobic face
is mostly buried (peptide autoassociation) and so the P/L interactions
are mostly hydrophobic and so weaker (ITC results). This explains why
no signal was observed in ITC using DOPC vesicles, while an interaction
was observed by PWR. This will be further discussed in the conclusion
section where a model is proposed to explain RW16 mode of action.
The ﬂuorescence of Trp has been studied to follow the change in
the Trp environment of RW16 following peptide/lipid interaction
(Fig S1). RW16 ﬂuorescence was monitored alone and upon contact
with LUVs composed of either DOPC or DOPG or both DOPC/DOPG
(8:2). The peptide concentration used was 0.5 μM, concentration at
which the peptide is oligomerized. In all cases a shift of theλmaxwas ob-
served toward lower wavelengths (called “blue-shift” or hypsochromic
shift) and an increase of theﬂuorescence intensity occurred. A blue-shift
reﬂects a change of environment of the Trp from a hydrophilic environ-
ment (buffer) to a hydrophobic environment due tomembrane adsorp-
tion or insertion [61]. In a polar environment the λmax is generally
around 350 nm whereas in a nonpolar environment the λmax is gener-
ally around 330–340 nm [61]. We have observed that in the presence
of DOPG LUVs the ﬁnal blue-shift is the same (from 347 nm to
338 nm; around 9 nm shift) but the concentration needed to reach
the half-shift of the Trp emission spectrum is around ten times smaller
in the case of DOPG LUVs than DOPC LUVs. This shift is consistent with
the partitioning of the Trp side chain into amore hydrophobic, sterically
conﬁned environment. The change in the Trp environment to a more
hydrophobic one can arise from peptide autoassociation where part of
the Trp residues would be in contact with each other or from a burial
of the Trp residue peptide in the lipid fatty acid chain region. At the
concentration used here (0.5 μM), thepeptide should be in the oligomer
form. We hypothesize that in the presence of DOPG LUVs the peptide
interacts with the membrane through electrostatic interactions, the
accumulation of peptide at the membrane surface will lead to strong
peptide/peptide oligomer repulsion and to a strongmembrane destabi-
lization. To release some of this electrostatic repulsion between the
peptide oligomers, some of the peptide molecules will ﬂip, inserting
the Trp residues deeper in the membrane which explains the blue-
shift observed. In the case of DOPC, the same mechanism will take
place, that is the ﬂip of the peptide molecules with the insertion of Trp
in the lipid fatty acid chain region (same magnitude of blue-shift
observed), the only difference being that here the concentration at
which this would take place is higher as there is no electrostatic attrac-
tionwith the lipid. Up to a certain concentration, the peptidewould stay
in solution, always in the form of oligomer, at increasing concentrations
the charge–charge repulsions between the peptide oligomers in solu-
tion increase and so the peptide interacts with the membrane and
ﬂips to insert the Trp residues in the membrane. This ﬂip around the
Arg residues has been reported to occur in parent peptides, RL9 and
RW9 (also amphipathic and with the same amino acid distribution
but shorter than RW16) by molecular dynamic simulation studies
[62]. In the mixture of DOPC/DOPG the concentration needed to reach
the same 9 nm blue-shift is around the same observed for DOPG
vesicles. So overall, the explanation is the same as that proposed for
DOPG but in the presence of a mixture of PC/PG it appears that there is
a competition between zwitterionic and anionic lipids. These results cor-
relatewell with calcein leakage andDSC experimentswhere an enhanced
lipid perturbation by the peptide in the presence of anionic lipids occurs.
Furthermore these results correlate well with ITC experiments showing
the importance of hydrophobic interaction between peptide and lipid,
compared to electrostatic interactions.
Fig. 7. CD spectra of RW16 in phosphate buffer and in the presence of LUVs of DOPC,
DOPE, DOPG, and DOPS (1 mg/mL) at a P/L ratio of 1/25 (47 μM of RW16).
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To determine whether the interaction of RW16 with membranes
leads to structural changes of the peptide, circular dichroismFig. 8. Cryo-TEMpictures of DOPC (A to D) and DOPG (E toH) LUVs (both at 1 mM)with RW16
C, D, G and H.experiments were performed in buffer (10 mM phosphate buffer)
and in the presence of lipid vesicles of different compositions (zwit-
terionic DOPC or DOPE or anionic DOPG or DOPS LUVs) and at P/L ra-
tios of 1/50, 1/25 and 1/10 (RW16 concentrations used varied from
24 μM to 111 μM). The peptide is thus in oligomeric form under all
the conditions. The CD spectra are presented in Fig. 7. Analysis of
CD spectra of RW16 in phosphate buffer demonstrated that the pep-
tide is mostly structured in random coil (54%) and α-helix (46%). In
the presence of zwitterionic lipids (DOPC or DOPE) the peptide sec-
ondary structure does not change signiﬁcantly. Indeed the percentage
of random coil is about 40% and the percentage of helix is about 60%
with DOPC whereas the percentage of random coil is about 60% and
the percentage of helix is about 40% with DOPE. In the presence of an-
ionic lipids (DOPG and DOPS) the peptide seems to change its struc-
ture into a β-sheet. Indeed in the presence of DOPG or DOPS
liposomes the percentage of random coil is about 40%, the percentage
of helix is about 20% and the percentage of β-sheet is about 40%. As
evidenced by Trp ﬂuorescence blue-shift, these results show that
RW16 binding to anionic lipids leads to a different secondary structure.
Such structural change in the presence of anionic lipidsmay be induced
by the strong accumulation in the membrane of peptide oligomers
possessing highly charged surfaces and thus leading to the formation
of aggregates with alterations in the peptide secondary structure. The
conformational changes under membrane binding observed in our
case are similar to those found in the literature for penetratin andat a P/L ratio of 1/25. Scale bars are: 500 nm for A and E, 100 nm for B and F, and 50 nm for
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β-structure on the vesicle surface charge density by peptide aggrega-
tion. The higher negative charge density may be more effective in neu-
tralizing the electrostatic repulsion between the positively charged
peptides, hence facilitating interactions between them.
One can note that a broad band appears at 230–233 nm in all the
spectra and that anionic membrane binding increases the intensity of
this band. In the literature, studies on Trp-rich antimicrobial peptides
(e.g., indolicidin) have attributed this signal to the Trp side chains
which can be either positive or negative depending on the orientation
of the Trp residues and their solvent exposition [64–66].
3.6. Cryo-TEM morphology analysis of liposomes in contact with the
peptide
Cryo-TEM was used to provide morphological and supramolecular
structural-information on membrane-bound RW16 assemblies, prin-
cipally in the context of its membrane-perturbation and aggregation
properties. Fig. 8 shows the representative images of DOPC LUVs
(Fig. 8A to D) and DOPG LUVs (Fig. 8E to H) both with RW16 at P/L
of 1/25. Fig. 8C and D shows that the morphology of zwitterionic lipo-
somes is not affected by peptide addition. In the case of anionic lipids
the result is quite different, the peptide largely deforms liposome struc-
tures and promotes liposome adhesion with great perturbation in the
liposome curvature (Fig. 8G and H). The peptide enhances the contactsFig. 9.Model proposed for the interaction of RW16 with zwitterionic vs anionic lipid model
left part of the liposome) and oligomeric (high concentration, right part of the liposome) for
model can be found in the Conclusions section.between the liposomes allowing them to deform and to create a more
compacted arrangement. Thereby, the peptide acts as “glue” between
anionic liposomes decreasing themembrane curvature tension. Another
aspect that differs between the two liposomes concerns thegeneral lipo-
some distribution in the grid, while in the case of PC they appear more
spreadly distributed (Fig. 8A) in the case of PG they are concentrated
in more restricted areas and appear to form aggregates (Fig. 8E). Indeed
one can observe that anionic vesicles are largely aggregated and this
aggregation induced by RW16 leads to their deformation. Again, this
enhanced membrane deformation observed in the case of anionic lipids
agrees with the other studies presented. If one compares this data with
previous data on penetratin [67,68], the peptide fromwhich RW16 was
derived, one can conclude that although both peptides highly per-
turb the lipid organization and membrane curvature, penetratin
has a disordering effect on the membrane while RW16 seems to
bring order in the membrane organization.
4. Conclusions
Herein, we have studied the interaction of a CPP with anti-tumor
activity, RW16, with different lipid model systems. As mentioned
above, RW16 has the capacity to autoassociate which changes and
complicates data analysis. Equilibrium between the monomeric and
oligomeric forms exists, low peptide concentrations (below 5 nM)
favor the monomeric form and high concentrations (above 5 nM) favorsystems (left vs right panels) and for the peptide in its monomeric (low concentration,
ms taking into consideration all experiments presented in this study. Discussion on the
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structure formation. The state of the peptide drastically changes its
lipid interaction: in themonomer state the peptide can have both hydro-
philic and hydrophobic areas exposed to solvent and so available for lipid
interactions; in the oligomer state the peptide will mostly present its hy-
drophilic face (hydrophobic face will be mostly buried in the oligomer
peptide core). This explains the disparity in the P/L afﬁnity measured
by PWR vs ITC experiments. Therefore, while at low nanomolar concen-
trations the peptide stays as a “monomer” and binds to the anionicmem-
brane with rather strong afﬁnity (~2 nM, PWR data), at micromolar
concentrations the peptide is aggregated and binds with a lower afﬁnity
to the bilayer (in the micromolar range, ITC data) (Fig. 9, stage I, left
panel). Binding of the peptide to anionic lipidswould occur at ﬁrst main-
ly by electrostatic interactions through the charged face of the peptide.
This results in a non-favorable exposure of the hydrophobic face of the
peptide. To deal with that the peptide either ﬂips around the Arg resi-
dues to insert Trp residues in the membrane core or autoassociates to
protect the hydrophobic face from the solvent. Peptide autoassociation
leads to liposome aggregation (stages II and III, left panel in Fig. 9). Lipo-
some aggregation can also result from the neutralization of the lipid
surface charge by peptide binding, that decreases electrostatic repulsion
leading to massive aggregation. The binding of the peptide to anionic
lipids is accompanied by a conformation change to a β-sheet structure.
In the presence of zwitterionic lipids, no binding was observed by ITC
because the peptide is at high concentrations and so in the oligomer
form, while in PWR an interaction is observed as the peptide is in the
monomer form (Fig. 9, stage I, right panel). At increasingpeptide concen-
trations, strong repulsions between the oligomers in solutionmay lead to
the partial disruption of this oligomers and insertion in the membrane,
the hydrophobic face of the peptide will be buried in the membrane
(stage II, right panel, Fig. 9). The peptide remains α-helical. Overall, the
experiments demonstrate that electrostatic interactions are important
for the interaction and so enhanced interactions and perturbations of
anionic lipids are observed relative to zwitterionic ones. This comes
logically after what was found previously regarding cationic cell-
penetrating peptide. Less expected is the fact that in the P/L interaction
the hydrophobic interactions rather than electrostatic ones seem to pre-
dominate. So, if the electrostatic interactions (between the Arg in the
peptide and the polar lipid headgroups) are important for a ﬁrst fast
membrane contact (Fig. 9, stage I), once this stage is passed the hydro-
phobic contacts (probably between the Trp residues and the fatty acid
chain region, following peptide ﬂip) become important (Fig. 9, stage II).
Equilibrium between ﬂipped and non-ﬂipped peptide is proposed
which in the case of non-ﬂipped peptide leads to a peptide oligomeriza-
tion to protect the peptide hydrophobic surface from the solvent (Fig. 9,
stage III, left panel). Indeed calorimetry studies demonstrate the impor-
tance of hydrophobic contacts and ﬂuorescent studies suggest that in
both types of lipids the Trp residues change to amore hydrophobic envi-
ronment, so inserted in the fatty acid chain region. A deeper insertion of
the peptide in zwitterionic vs anionic lipids is suggested by DSC studies,
probably resulting from the fact that in anionic lipids the peptidemay be
retained more at the surface due to the electrostatic interactions with
the lipid headgroups (Fig. 9, stage I left panel vs right panel). The
accumulation of peptide in the membrane, either in its monomeric or
oligomeric form, will create a mass imbalance in the membrane that
can lead to the formation of pores or defects in the membrane allowing
peptide passage. This step, in the case of anionic lipids, is accompanied
by stronger membrane perturbations with liposome oligomerization
(Fig. 9, stage III, left panel) and the formation of other type of lipid supra-
molecular structures (as shown by Cryo-TEM). Aside from a preferential
interaction with anionic lipids, RW16 would have the capacity of
recruiting these lipids from binary lipid mixtures as shown by DSC.
This is interesting when considering real cell membranes, for example
fromcancer cells that contain a fewamounts of anionic lipids.When con-
densed in small domains these minor lipid components may present an
increasedpotential. The enhanced interaction andperturbation observedin RW16 interaction with anionic lipids is interesting when considering
the reported potential of this peptide in selectively affecting the motility
and intracellular actin-remodeling activity of tumor cells [10]. Cancer cell
membranes being particularly more anionic than those of healthy cells
due to the presence of anionic lipids in their outer leaﬂet (PS mainly)
and overexpression in certain proteoglycans (also rich in negative
charges), such enhanced effect of RW16 on anionic membranes
may explain its potential as possible anticancer agent. Indeed recent
studies pointed to a selectivity of certain CPPs to cancer cells and
tumors [12–14].
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.02.008.Acknowledgements
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